Lexology March 30, 2020
Katten Muchin Rosenman LLP

On March 27, President Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act or the Act). This $2.2 trillion package is designed to provide relief to those impacted by the COVID-19 crisis. This Advisory provides a high-level summary of key sections of the Act that impact the health care industry. The Act does the following:

Coverage of Diagnostic Testing for COVID-19

  • Requires health insurers and group health plans to cover diagnostic tests that can either detect SARS-CoV-2 or diagnose COVID-19 in a manner that does not impose cost-sharing or medical management requirements on individuals, as long as the tests meet certain criteria, such as the test being authorized under the U.S. Food and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Healthcare System, Provider, Regulations, Trends
EU regulation: AI Act will mean a raft of new requirements for ‘high-risk’ systems
Manatt Launches Health AI Policy Tracker
2023 Patient Access: State Legal and Regulatory Environment Survey Objectives and Strategies
A health tech leader’s plea: Regulate AI
Regulations, Innovations and AI Define This Week in Big Tech

Share This Article